Science 37 Holdings Inc (SNCE) Stock
SNCE is no longer traded. Science 37 Holdings was delisted from the Nasdaq in March 2024.
Prices on this page are historical; the last trade was March 11, 2024 at $5.75.
Science 37 Holdings stock price history
SNCE final trading statistics
- Final close
- $5.75
- Final trading day
- Mar 11, 2024
- Market cap at delisting
- $34.66M
- Shares outstanding
- 6.03M
- Final 52-week range
- $0.19 – $7.39
- Avg. volume (final 3 mo.)
- 54,277
- All-time high (split-adj.)
- $282.00 · Nov 2021
- All-time low (split-adj.)
- $4.09 · Dec 2023
- Return since IPO
- -42.8%
- Beta
- 0.56
- Book value / share
- $8.69
- Price / book
- 0.66
Science 37 Holdings annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2023 | $60.26M | -$124.7M | — |
| FY2022 | $70.15M | -$51.0M | -$0.66 |
| FY2021 | $23.70M | -$32.4M | -$5.11 |
| FY2020 | $23.70M | -$32.4M | -$3.22 |
| FY2019 | — | -$1.0K | -$0.68 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Science 37 Holdings Inc
Science 37 Holdings, Inc. engages in patient-centric clinical trial activities in North Carolina. Its platform enables modern and digital approaches to clinical research, including the patient and trial investigators, nurses, coordinators, and sponsors, standardize evidence generation, and harmonize data. The company's platform also provides specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators, and connected devices for orchestrating clinical trials; and extensive configuration to support virtually any phase of clinical study and therapeutic area. In addition, the company licenses its proprietary hosted technology platform to various life science institutions. It serves large and mid-sized pharmaceutical companies, contract research organizations, academic institutions, and biotech companies. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. As of March 11, 2024, Science 37 Holdings, Inc. operates as a subsidiary of eMed, LLC.
Science 37 Holdings stock FAQ
What happened to Science 37 Holdings stock?
Science 37 Holdings stock was delisted from the Nasdaq. Its final close was $5.75 on March 11, 2024.
Is SNCE stock still trading?
No. SNCE was delisted from the Nasdaq in March 2024 and no longer trades on a U.S. exchange.
What was the last price of SNCE stock?
SNCE closed at $5.75 on its final trading day, March 11, 2024, for a market value of about $34.66M.
What were Science 37 Holdings's revenue and earnings in its last full fiscal year?
Science 37 Holdings reported revenue of $60.26M and net income of -$124.7M in fiscal 2023, its last full year as a public company.
When did Science 37 Holdings go public?
Science 37 Holdings Inc stock began trading on November 20, 2020.